Xylo
Pre-clinicalDiscover how XYLO's breakthrough brain therapies are revolutionizing treatment for neurological and psychiatric conditions through targeted neural circuit enhancement.
Founded
2021
Focus
Psychedelics
About
Discover how XYLO's breakthrough brain therapies are revolutionizing treatment for neurological and psychiatric conditions through targeted neural circuit enhancement.
Company Info
TypePrivate
Founded2021
LocationSan Francisco, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile